Global bond yields are trending higher as investors demand more compensation for inflation and growth risks. That puts extra focus on companies that can fund themselves from solid cash generation rather than relying heavily on debt. This is where the Undervalued Stocks Based On Cash Flows screener can help. It highlights stocks priced below SWS DCF fair value. This article walks through three standouts from that list.
The three stocks covered below are just a small sample, and the full screen surfaced 136 more companies with equally compelling cash flow and valuation stories that are not included here. If you want to go straight to the source, head into the Undervalued Stocks Based On Cash Flows screener to identify and analyze the ideas that best fit your own checklist.
United States Antimony (UAMY)
Overview: United States Antimony is a Dallas based producer of antimony, zeolite, and precious metals that supplies materials used in flame retardants, batteries, filtration, environmental cleanup, and a wide range of industrial applications across the US and Canada.
Operations: The company generates about $32 million of revenue from antimony products and about $4 million from zeolite, with roughly $35 million of total sales coming from the United States and about $2 million from Canada.
Market Cap: US$799 million
United States Antimony is drawing attention because it sits at the intersection of critical minerals policy and specialty materials demand, yet still carries clear execution and funding risks. The company has unique exposure to antimony used in flame retardants and batteries, plus zeolite used in filtration and environmental remediation, alongside early progress on US government contracts through the Defense Logistics Agency. Analysts expect strong revenue and earnings growth and see upside to their DCF based fair value, although recent results were hit by lower antimony prices and the company remains unprofitable with a short cash runway and reliance on external funding. For investors, the key consideration is whether capacity expansion, new ore sources and government engagement can outweigh permitting hurdles, price volatility and balance sheet pressure.
United States Antimony sits at the crossroads of critical minerals policy and specialty materials demand. Yet the real story is how its funding needs and cash runway interact with early government support in the United States Antimony financial health report
Build your own cash flow and balance sheet shortlist
United States Antimony and the two other stocks in this article all came from a single screen, but the main benefit for you is shaping your own filters. Use our Screener to combine valuation, cash flows, balance sheet strength and risk checks, or start with any of our curated Investing Ideas.
AECOM (ACM)
Overview: AECOM is a Dallas based infrastructure consulting company that helps governments and corporations plan, design, manage, and in some cases invest in major projects across transportation, water, energy, environmental, and real estate markets worldwide.
Operations: AECOM generates about $11.8b of revenue from its Americas segment, around $3.6b from International operations, and only a small contribution from its AECOM Capital segment.
Market Cap: US$8.2b
AECOM may appeal to investors seeking exposure to long term infrastructure and climate related spending without owning a construction contractor. The company focuses on higher margin consulting and design work, supported by record order wins and a large backlog, while also investing in digital tools and AI to improve how projects are delivered. At the same time, recent cost issues on a legacy construction management project, a large $337 million charge, and expected cash flow pressure into 2027 illustrate the risks associated with complex multi year contracts. The key question for investors is how the growing design and advisory portfolio and analyst support compare with those legacy risks and AECOM’s reliance on government funded projects.
AECOM’s consulting engine and digital tools sit on one side of the story, while legacy project risks sit on the other. Get the full picture in the 4 key rewards and 2 important warning signs (1 is major!)
Cerebras Systems (CBRS)
Overview: Cerebras Systems is an AI infrastructure company that builds wafer scale chips and rack based systems designed to run demanding inference and Generative AI workloads at very high speeds for data centers and supercomputer scale deployments. Its platforms are used by hyperscalers, AI labs, enterprises and Sovereign AI programs across the United States and international markets.
Operations: Cerebras Systems generates about $680.7 million of revenue from semiconductors, with roughly $236.6 million coming from the United States and about $443.5 million from Europe, the Middle East and Africa.
Market Cap: US$54.9b
Cerebras Systems stands out because its wafer scale engine targets the bottleneck in real time AI inference, and that is showing up in both its financial profile and commercial traction. Core revenue in Q2 2026 reached $209.9 million, supported by a Remaining Performance Obligation of about $25.4b tied to customers such as OpenAI and AWS, while cloud revenue growth has been very large as more inference workloads move onto its platform. At the same time, the company remains loss making, relies on external borrowing, and the share price has been highly volatile with meaningful insider selling and a premium valuation. For investors, the mix of rapid expected revenue and earnings growth, strong backlog visibility and genuine funding and concentration risks is exactly what makes Cerebras worth a closer look.
Revenue momentum, a US$25.4b Remaining Performance Obligation and marquee customers put Cerebras Systems in rare territory. The real question is what the analyst forecasts for Cerebras Systems are hinting at for the next phase of this story.
Seeking Alternatives Before The Crowd Moves?
Fresh ideas often see momentum build quietly before a breakout. Do not get caught reacting late while stocks are already flying. Use these focused lists and take action in a timely way.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com